GL1X · GenesisL1 explorer

MolNFT v1 · #22963 · protein

Structural aspects of inotropic bipyridine binding: crystal structure determination to 1.9 ångströms of the human serum transthyretin- milrinone complex

1TLM: “Structural aspects of inotropic bipyridine binding: crystal structure determination to 1.9 ångströms of the…”. X-ray diffraction, 1 ligand (MIL), 2 pockets (best druggability 0.33). MolNFT v1 #22963 on GenesisL1: 3D structure…

PDB
1TLM
Type
protein
Length
243 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
MIL
Pockets
2 · best druggability 0.33

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1235% helix, 48% strandP02766
BTransthyretinprotein1206% helix, 48% strandP02766

Ligands and binding sites

  • MIL · Milrinone · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1700.330.7615empty
2760.310.7414empty

Interfaces

1 interface between chains.

  • A–B · 911 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 1TLM · Structural aspects of inotropic bipyridine binding: crystal structure determination to… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.